维普中文期刊产品整合服务
19篇 您的检索式:作者名="Advani AS"
    题名 作者 年代 出处 被引量
1The treatment of adolescents andyoung adults with acute lymphoblastic leukemia 显示文摘LUKENBILL J ADVANI AS 2013CurrHematol Malig Rep2013,8,2:1
2Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML 显示文摘Advani AS Rodriguez C Jin T 2008Leuk Res2008,32,6:1
3C-kit as a target in the treatment of acute myelogenous leukemia显示文摘Advani AS 2005Curr Hematol Rep2005,4,1:1
4Increased C-kit inten- sity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML显示文摘Advani AS Rodriguez C Jin T 2008Leuk Res2008,32,6:1
5FLT3 and acute myelogenous leukemia: biology, clinical significance and therapeutic applications 显示文摘Advani AS 2005Curt Pharm I)es2005,11,26:1
6Bcr-Abl variants: biological and clinical aspects 显示文摘Advani AS Pendergast AM 2002Leuk Res2002,26,8:1
7When, how, and what cell source for hematopoietic cell transplantation in first complete remission adult acute lymphoblastic leukemia显示文摘Lazarus HM Advani AS 2012Hematology Am Soc Hematol Edue Program2012,2012,:1
8FLT3 and acute myelogenous leukemia:biology,clinical significance and therapeutic applications显示文摘Advani AS 2005Curr Pharm Des2005,11,26:1
9Increased C-kit intensity is apoor prognostic factor for progression-free and overall survival inpatients with newly diagnosed AML显示文摘Advani AS Rodriguez C Jin T 2008Leuk Res2008,32,:1
10FLT3 and acute myelogenous leukemia:biology,clinical significance and therapeutic applications显示文摘Advani AS 2005Curr Pharm Des2005,11,26:1
11C-kit as a target in the treatment of acute myelogenous leukemia显示文摘Advani AS 2005Curr Hematol Rep2005,4,1:1
12Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia显示文摘Advani AS Jin T Ramsingh G 2008Leuk Lymphoma2008,49,8:1
13When, how, and what cell source for hematopoietie cell transplantation in first complete remission adult acute lymphoblastic leukemia? 显示文摘Lazarus HM Advani AS 2012Hematology Am Soc Hematol Educ Program2012,2012,:1
14Increased C-kit intensity is apoor prognostic factor for progression-free and overall survival in pa-tients with newly diagnosed AML显示文摘Advani AS Rodriguez C Jin T 2008Leuk Res2008,32,:1
15Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia显示文摘Advani AS Jin T Ramsingh G 2008Leuk Lymphoma2008,49,:1
16Bcr-Abl variants:biological and clinical aspects显示文摘Advani AS Pendergast AM 2002Leuk Res2002,26,8:1
17Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML显示文摘Advani AS Rodrignez C Jin T 2008I_oak Ros2008,32,6:1
18Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia 显示文摘PORTELL CA WENZELL CM ADVANI AS 2013Clin Pharmacol2013,5,1:1
19Increased C - kit intensity is a poor prognostic factor for progression - free and overall survival in pa- tients with newly diagnosed AML显示文摘Advani AS Rodriguez C Jin T 2008Leuk Res2008,32,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费